Join Us Next Year September 20-23, 2021
Boston Convention and Exhibition Center,
Proudly Part of Biotech Week Boston
The cell and gene therapy event for ground breaking bioprocessing, manufacturing & supply chain strategies
Revolutionize your cell, gene & gene edited ex vivo cell therapy programs as world renowned leaders share the latest analytical techniques & vector technologies at this global event
2020 EVENT!
In light of the current global climate, it is more important than ever for the cell & gene therapy community to connect with one another, strategize and share ideas – All in a safe, responsible way. With our dedication to address the most pressing issues, our cell and gene therapy events, took place in October this year, moving to an all-digital format and offering attendees the ability to participate in virtual content, exhibits and networking opportunities.
Cell Therapy
Cell Therapy
- Push the boundaries of process development with novel considerations & strategies
- Transition to a more standardizes approach to raw material selection & supply
- Improve confidence in your supply chain with next generation manufacturing and cryo techniques
Gene Edited Ex Vivo Cell Therapy
Gene Edited Ex Vivo Cell Therapy
- Build a strategy for next generation allogeneic CAR & T cell therapies
- Get to grips with different manufacturing infrastructures & commercialization strategies
- Understand effective testing, characterization & validation approaches
In Vivo Gene Therapy
In Vivo Gene Therapy
- Optimize next generation cell lines and address the current challenges with viral vectors
- Work towards continuous bioprocessing of vectors with enabling manufacturing tech
- Ensure high throughput applications in downstream processing
LEARN FROM THE BRIGHTEST MINDS IN CELL & GENE THERAPY
Each year, CGT's scientific agenda includes 100+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of Cell & Gene Therapy development and production. Below are some of the speakers who participated on our 100% Virtual Cell & Gene Therapy Bioprocessing & Commercialization Conference & Exhibition, which ran this past October 2020.
Cell & Gene Therapy techniques and technologies
On-demand content that was offered during our 2020 Event
Assessing the Future Prospects of Upstream Bioprocessing Systems for Commercial AAV Production
Scott Jeffers, Director, UniQure, USA
Raw Materials: BOMs, Risks & Securing Supply
Tom Walls, Associate Director Supply Chain, bluebird bio, USA
AI in Cell and Gene Therapy Manufacturing
Michael Roberts, Chief Technology Officer (Europe), Asklepios
BioPharmaceutical, Inc., UK
Product Dependent Cryopreservation Protocols
David McKenna, Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Minnesota, USA
Fresh vs. Cryopreserved: Tightening up Supply Chains
Jason Acker, Professor, Laboratory Medicine and Pathology, University of Alberta, Canada
Implementation of “off the shelf” Closed Systems fit for every purpose
Ali Mohamed, VP, CMC, Immatics, USA
CONNECT WITH KEY BUYERS AT Cell & Gene Therapy 2021
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
(Companies A-L) Contact Kristin Skahan: Kristin.Skahan@informa.com | +1-857-504-6730
(Companies M-Z) Contact Perri Lucatello: Perri.Lucatello@informa.com | +44 (0)20 7017 7247
